457496621
21 Oct 2020
United States Intellia Therapeutics Receives Authorization to Initiate Phase 1 Clinical Trial of NTLA-2001 for Transthyretin Amyloidosis , United states
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.